217 related articles for article (PubMed ID: 28466374)
1. The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis.
Kuo YH; Wu IP; Wang JH; Hung CH; Rau KM; Chen CH; Kee KM; Hu TH; Lu SN
Invest New Drugs; 2018 Apr; 36(2):307-314. PubMed ID: 28466374
[TBL] [Abstract][Full Text] [Related]
2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
3. Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Jeong SW; Jang JY; Shim KY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim KH; Kim JH
Gut Liver; 2013 Nov; 7(6):696-703. PubMed ID: 24312711
[TBL] [Abstract][Full Text] [Related]
4. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
Komatsu S; Ueshima K; Kido M; Kuramitsu K; Tsugawa D; Yanagimoto H; Toyama H; Ku Y; Kudo M; Fukumoto T
J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):303-314. PubMed ID: 36047804
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
Zheng K; Zhu X; Fu S; Cao G; Li WQ; Xu L; Chen H; Wu D; Yang R; Wang K; Liu W; Wang H; Bao Q; Liu M; Hao C; Shen L; Xing B; Wang X
Radiology; 2022 May; 303(2):455-464. PubMed ID: 35103539
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
Tao ZW; Cheng BQ; Zhou T; Gao YJ
Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
[TBL] [Abstract][Full Text] [Related]
7. Indication for surgical resection in patients with hepatocellular carcinoma with major vascular invasion.
Higaki T; Yamazaki S; Moriguchi M; Nakayama H; Kurokawa T; Takayama T
Biosci Trends; 2017 Nov; 11(5):581-587. PubMed ID: 29021421
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein and
Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib
Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Anticancer Res; 2020 Apr; 40(4):2283-2290. PubMed ID: 32234927
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report.
Narita H; Kawaratani H; Shibamoto A; Takeda S; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Nishimura N; Hokuto D; Sho M; Yoshiji H
Clin J Gastroenterol; 2022 Oct; 15(5):953-959. PubMed ID: 35773571
[TBL] [Abstract][Full Text] [Related]
11. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
Takada H; Kurosaki M; Nakanishi H; Takahashi Y; Itakura J; Tsuchiya K; Yasui Y; Tamaki N; Takaura K; Komiyama Y; Higuchi M; Kubota Y; Wang W; Okada M; Enomoto N; Izumi N
PLoS One; 2018; 13(6):e0198812. PubMed ID: 29912922
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein.
Ban D; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T
J Gastrointest Surg; 2009 Nov; 13(11):1921-8. PubMed ID: 19727969
[TBL] [Abstract][Full Text] [Related]
13. Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Hsu PY; Cheng TS; Chuang SC; Chang WT; Liang PC; Hsu CT; Wei YJ; Jang TY; Yeh ML; Huang CI; Lin YH; Wang CW; Hsieh MY; Hou NJ; Hsieh MH; Tsai YS; Ko YM; Lin CC; Chen KY; Dai CY; Lin ZY; Chen SC; Huang JF; Chuang WL; Huang CF; Yu ML
Cancer Med; 2022 Jan; 11(1):104-116. PubMed ID: 34786871
[TBL] [Abstract][Full Text] [Related]
14. [A case of curative resection for advanced hepatocellular carcinoma with portal vein tumor thrombus after hepatic arterial infusion chemotherapy].
Ishizaki M; Kaibori M; Matsui K; Nakatake R; Matsushima H; Sakaguchi T; Kwon AH
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1991-3. PubMed ID: 23267953
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors.
Jiao T; Tang H; Zhang W; Hu B; Wan T; Cao Y; Zhang Z; Wang Y; Cao J; Cui M; Lu S
BMC Surg; 2023 Dec; 23(1):384. PubMed ID: 38114938
[TBL] [Abstract][Full Text] [Related]
16. Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection.
Irtan S; Chopin-Laly X; Ronot M; Faivre S; Paradis V; Belghiti J
Liver Int; 2011 May; 31(5):740-3. PubMed ID: 21457447
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Ramucirumab
Maesaka K; Sakamori R; Yamada R; Tahata Y; Ohkawa K; Oshita M; Tamura S; Hagiwara H; Mita E; Yakushijin T; Inada M; Kodama T; Hikita H; Tatsumi T; Takehara T
Anticancer Res; 2021 Apr; 41(4):2187-2192. PubMed ID: 33813432
[TBL] [Abstract][Full Text] [Related]
18. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
Salem R; Lewandowski R; Roberts C; Goin J; Thurston K; Abouljoud M; Courtney A
J Vasc Interv Radiol; 2004 Apr; 15(4):335-45. PubMed ID: 15064336
[TBL] [Abstract][Full Text] [Related]
19. Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review.
Kim TS; Kim JH; Kim BH; Lee YS; Yoo YJ; Kang SH; Suh SJ; Jung YK; Seo YS; Yim HJ; Yeon JE; Byun KS
Clin Mol Hepatol; 2017 Dec; 23(4):340-346. PubMed ID: 28633200
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]